Related Experiment Video
Updated: Sep 3, 2025

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Human Granulocytic Anaplasmosis-A Systematic Review of Published Cases
Igor Dumic1,2, Dorde Jevtic3,4, Mladjen Veselinovic5
1Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.
Abstract:
Anaplasma phagocytophilum is an emerging, Gram-negative, obligate intracellular pathogen that is transmitted by a tick vector. Human infection ranges from asymptomatic to severe disease that can present with pancytopenia, multiorgan failure, and death. The aim of this systematic review is to analyze case reports and case series reported over the last two decades in peer-reviewed journals indexed in the Medline/PubMed database according to the PRISMA guidelines. We found 110 unique patients from 88 case reports and series. The most common mode of transmission was tick bite (60.9%), followed by blood transfusion (8.2%). Infection was acquired by blood transfusion in nearly half (42%) of the immunocompromised patients. Most patients reported fever (90%), followed by constitutional (59%) and gastrointestinal symptoms (56%). Rash was present in 17% of patients, much higher than in previous studies. Thrombocytopenia was the most common laboratory abnormality (76%) followed by elevated aspartate aminotransferase (AST) (46%). The diagnosis was most commonly established using whole-blood polymerase chain reaction (PCR) in 76% of patients. Coinfection rate was 9.1% and Borrelia burgdorferi was most commonly isolated in seven patients (6.4%). Doxycycline was used to treat 70% of patients but was only used as an empiric treatment in one-third of patients (33.6%). The overall mortality rate was 5.7%, and one patient died from trauma unrelated to HGA. The mortality rates among immunocompetent and immunocompromised patients were 4.2% (n = 4/95) and 18.2% (n = 2/11), respectively. Four of the six patients who died (66.6%) received appropriate antibiotic therapy. Among these, doxycycline was delayed by more than 48 h in two patients.
Insights
Anaplasma phagocytophilum, a tick-borne illness, presents with fever and thrombocytopenia. Early doxycycline treatment is crucial, especially for immunocompromised individuals, to reduce mortality from this emerging infectious disease.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Anaplasma phagocytophilum is an emerging tick-borne pathogen causing human granulocytic anaplasmosis (HGA).
- Infections range from asymptomatic to severe, potentially leading to multiorgan failure and death.
Purpose of the Study:
- To systematically review case reports and series of Anaplasma phagocytophilum infections over the past two decades.
- To analyze transmission routes, clinical presentations, laboratory findings, diagnostic methods, coinfections, treatment, and outcomes.
Main Methods:
- Systematic review of peer-reviewed case reports and series indexed in Medline/PubMed.
- Adherence to PRISMA guidelines for data extraction and analysis.
- Inclusion of 110 unique patients from 88 publications.
Main Results:
- Tick bites were the primary transmission route (60.9%); blood transfusion was significant in immunocompromised patients (42%).
- Common symptoms included fever (90%), constitutional (59%), and gastrointestinal issues (56%); rash occurred in 17%.
- Thrombocytopenia (76%) and elevated AST (46%) were key lab findings; PCR confirmed diagnosis in 76%.
Conclusions:
- Anaplasma phagocytophilum infections require prompt diagnosis and treatment, with doxycycline being the primary antibiotic.
- Immunocompromised individuals face higher mortality risks (18.2%) compared to immunocompetent patients (4.2%).
- Delayed doxycycline administration, even with appropriate therapy, was noted in fatal cases, highlighting the importance of timely intervention.

